Results 301 to 310 of about 101,449 (340)

Digoxin-verapamil interaction

Clinical Pharmacology and Therapeutics, 1981
To explore a possible interaction between digoxin and verapamil, a single-dose kinetic study of digoxin was performed and then repeated after 10 days of verapamil treatment in eight healthy subjects. Verapamil diminished the apparent central distribution volume of digoxin from 0.83 +/- 0.25 to 0.64 +2- 0.17 l/kg (P less than 0.05) and reduced total ...
Niels Anders Klitgaard, Knud Erik Pedersen, Steffen Hvidt, Folmer Nielsen-Kudsk, Anton Dorph-Pedersen   +4 more
openaire   +2 more sources

Parkinsonism Unmasked by Verapamil

Clinical Neuropharmacology, 1993
We report the case of a 55-year-old man who had a parkinsonian syndrome unresponsive to levodopa for 5 years and had been taking verapamil during the past 8 years. Parkinsonian signs improved markedly after withdrawal of verapamil, suggesting its role in unmasking the parkinsonism.
Esteban García-Albea, Félix Javier Jiménez-Jiménez, F. Cabrera-Valdivia, A Vaquero, Jose Tejeiro, Lucía Ayuso-Peralta   +5 more
openaire   +3 more sources

Verapamil in the Treatment of Hypertension

Journal of Cardiovascular Pharmacology, 1981
A randomized, double-blind, crossover trial was carried out in 17 hypertensive patients to evaluate the hypotensive efficacy and safety of verapamil. Verapamil in doses of 120 mg thrice daily was compared with pindolol in doses of 7.5 mg twice daily. A thiazide diuretic was given with both drugs.
Austin E. Doyle, S. N. Anavekar, Christophidis N, William J. Louis   +3 more
openaire   +3 more sources

Pharmacokinetics of verapamil in overdose

Human & Experimental Toxicology, 1997
The information on the pharmacokinetics of verapamil in overdose is scanty. We report two adults who ingested 3.2 g and 4 g ofverapamil, respectively. Both patients had hypotension and a severe bradycardia. The highest plasma verapamil concentration in these patients was about 2200 ng/ml and 2700 ng/ml, respectively.
Leo Tarssanen, Kari T. Kivistö, Pertti J. Neuvonen   +2 more
openaire   +3 more sources

Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose

Clinical toxicology, 2011
Context. Intralipid® infusion is useful in reversing cardiac and central nervous system toxicity of local anesthetic drugs, and recent reports suggest utility in other drug overdoses. Case details.
D. French, P. Armenian, Weiming Ruan, A. Wong, K. Drasner, K. Olson, A. Wu   +6 more
semanticscholar   +1 more source

The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis

European journal of emergency medicine, 2011
Objective Verapamil and adenosine are the most common agents used to treat paroxysmal supraventricular tachycardia (PSVT). We performed a systematic review and meta-analysis to determine the relative effectiveness of these drugs and to examine their ...
B. Delaney, J. Loy, A. Kelly
semanticscholar   +1 more source

Clinical Use of Verapamil

Drugs, 1977
Verapamil, a derivative of papaverine, originally developed as an antianginal drug is a highly effective antiarrhythmic drug against supraventricular tachyarrhythmias when administered intravenously. It is not a ~-adrenoceptor blocking agent (~-blocker) and differs from other antiarrhythmic agents in its mode of action.
openaire   +3 more sources

Verapamil and depression

American Journal of Psychiatry, 1984
Lewis Ha, Bacher Nm
openaire   +3 more sources

Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway

Pharmaceutical Research, 2018
M. Melone, Clemente Dato, S. Paladino, Cinzia Coppola, C. Trebini, M. Giordana, L. Perrone   +6 more
semanticscholar   +1 more source

Verapamil-induced Parkinsonism

The American Journal of Medicine, 1995
Clara C. Faura, María Navarro, JoséF. Horga, María D. Padrell   +3 more
openaire   +3 more sources